About Vaccinogen
Vaccinogen, Inc. operates as a biotechnology company that develops OncoVAX, an Active Specific Immunotherapy (ASI) vaccine which uses the patient's own cancer cells to block the return of colon cancer following surgery. The company was incorporated in 2007 and is based in Frederick, Maryland.
|
|
|
1-10 employees
View all Vaccinogen employees
|
|
IT Services and IT Consulting
|
|
301-668-8400
|
|
Frederick, MD
|
|
2007
|
Vaccinogen Alternatives
Frequently Asked Questions about Vaccinogen
David Oxley is the CEO of Vaccinogen.
The decision makers in Vaccinogen are David Oxley, Michael Hanna, Dinand Van Der Linde, etc. Click to Find Vaccinogen decision makers emails.
Vaccinogen Staff Directory
Search Vaccinogen Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
